GelSana Therapeutics, Inc.
Wednesday, June 05, 2024
Start-Up Stadium Session
Inflammation
5B
Company Description: GelSana’s novel polymers improve healing in impaired wounds, particularly in chronic wounds with high inflammation. They improve healing by quenching overactive inflammation and repelling bacteria. They are easy to apply and remain stable for an extended period. The polymers are capable of controlled drug delivery as well, thus providing future product opportunities for wounds prone to infection or severe wounds needing therapeutics to resolve.
Company Website:
https://gelsanatherapeutics.com
Company HQ City
Aurora
Company HQ State
CO
Company HQ Country
United States
CEO/Top Company Official
Melissa Krebs, Ph.D.
Primary Speaker